A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicine

被引:68
作者
Kawamoto, Kensaku [1 ,2 ]
Lobach, David F. [1 ]
Willard, Huntington F. [2 ]
Ginsburg, Geoffrey S. [2 ]
机构
[1] Duke Univ, Med Ctr, Dept Community & Family Med, Div Clin Informat, Durham, NC 27710 USA
[2] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA
来源
BMC MEDICAL INFORMATICS AND DECISION MAKING | 2009年 / 9卷
关键词
SERVICE-ORIENTED ARCHITECTURE; HEALTH-CARE; PREVENTIVE CARE; DATA STANDARDS; PHARMACOGENETICS; INFORMATION; PROTEOMICS; THERAPY; IMPLEMENTATION; METABOLOMICS;
D O I
10.1186/1472-6947-9-17
中图分类号
R-058 [];
学科分类号
摘要
Background: In recent years, the completion of the Human Genome Project and other rapid advances in genomics have led to increasing anticipation of an era of genomic and personalized medicine, in which an individual's health is optimized through the use of all available patient data, including data on the individual's genome and its downstream products. Genomic and personalized medicine could transform healthcare systems and catalyze significant reductions in morbidity, mortality, and overall healthcare costs. Discussion: Critical to the achievement of more efficient and effective healthcare enabled by genomics is the establishment of a robust, nationwide clinical decision support infrastructure that assists clinicians in their use of genomic assays to guide disease prevention, diagnosis, and therapy. Requisite components of this infrastructure include the standardized representation of genomic and non-genomic patient data across health information systems; centrally managed repositories of computer-processable medical knowledge; and standardized approaches for applying these knowledge resources against patient data to generate and deliver patient-specific care recommendations. Here, we provide recommendations for establishing a national decision support infrastructure for genomic and personalized medicine that fulfills these needs, leverages existing resources, and is aligned with the Roadmap for National Action on Clinical Decision Support commissioned by the U.S. Office of the National Coordinator for Health Information Technology. Critical to the establishment of this infrastructure will be strong leadership and substantial funding from the federal government. Summary: A national clinical decision support infrastructure will be required for reaping the full benefits of genomic and personalized medicine. Essential components of this infrastructure include standards for data representation; centrally managed knowledge repositories; and standardized approaches for leveraging these knowledge repositories to generate patient-specific care recommendations at the point of care.
引用
收藏
页数:14
相关论文
共 76 条
[1]   The state of regional health information organizations: Current activities and financing [J].
Adler-Milstein, Julia ;
McAfee, Andrew P. ;
Bates, David W. ;
Jha, Ashish K. .
HEALTH AFFAIRS, 2008, 27 (01) :W60-W69
[2]  
*AMIA STRAT IN PRO, MORN IN
[3]  
[Anonymous], 2011, Clinical Decision Support (CDS) and Meaningful Use Frequently Asked Questions
[4]  
[Anonymous], REAL POT PHARM OPP C
[5]   Pharmacogenetics of antihypertensive treatment [J].
Arnett, DK ;
Claas, SA ;
Glasser, SP .
VASCULAR PHARMACOLOGY, 2006, 44 (02) :107-118
[6]  
Balas E A, 2000, Yearb Med Inform, P65
[7]   NCBI GEO: mining tens of millions of expression profiles - database and tools update [J].
Barrett, Tanya ;
Troup, Dennis B. ;
Wilhite, Stephen E. ;
Ledoux, Pierre ;
Rudnev, Dmitry ;
Evangelista, Carlos ;
Kim, Irene F. ;
Soboleva, Alexandra ;
Tomashevsky, Maxim ;
Edgar, Ron .
NUCLEIC ACIDS RESEARCH, 2007, 35 :D760-D765
[8]   Proteomics from the clinical perspective: many hopes and much debate [J].
Beretta, Laura .
NATURE METHODS, 2007, 4 (10) :785-786
[9]   HIV resistance testing in the USA - a model for the application of parmacogenomics in the clinical setting [J].
Blum, RA ;
Wylie, N ;
England, T ;
French, C .
PHARMACOGENOMICS, 2005, 6 (02) :169-179
[10]   Biomedical informatics for proteomics [J].
Boguski, MS ;
McIntosh, MW .
NATURE, 2003, 422 (6928) :233-237